Nurix Therapeutics에 대한 매도 수량은 투자자에게 Nurix Therapeutics의 주식 하락에 베팅하는 정도를 알려줍니다. 매도 수량 데이터는 2주마다 업데이트됩니다.

Nurix Therapeutics (NASDAQ:NRIX) 주식, 공매도 수량 보고

NURIX THERAPEUTICS INC

Nurix Therapeutics

Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies.

Stuttgart,,Germany,-,03-11-2021:,Person,Holding,Cellphone,With,Company,Logo

Equities

News

Markets

ETFs

ADPT

ARKQ

NRIX

NVDA

PATH

수요일(23일) 캐시 우드가 이끄는 아크 인베스트는 엔비디아(NASDAQ:NVDA)와 AMD(NASDAQ:AMD)에 대한 노출을 증가시켰다. 이러한 거래는 반도체 산업에서 지속적인 도전 과제, 특히 미국의 제재가 중국에 대한 칩 판매에 영향을 미치고 있는 상황에서 이루어졌다.

캐시 우드, 엔비디아·AMD 주식 추가 매입···수출 규제 앞두고 중국 기술 업체들은 칩 대량 비축

Responding To Regulatory Scrutiny

Broad U.S. Equity ETFs

Education

Specialty ETFs

Tech

ARKG

ARKK

CDNA

COIN

CRSP

HOOD

IONS

NTRA

PLTR

RBLX

ROKU

RXRX

SHOP

TSLA

TWST

VYCT

캐시 우드가 이끄는 아크 펀드(Ark Funds)는 미래 성장 혁신 분야에 중점을 두고 적극적으로 관리되는 ETF들 덕분에 가장 잘 알려진 펀드 매니저 중 하나이다. 이 펀드의 ETF 두 개가 목요일에 10주년을 맞이했다. 이들 펀드의 출시와 지난 10년 동안의 성과를 살펴보겠다.

캐시 우드의 아크 이노베이션, 지노믹스 ETF가 10주년을 기념: 연간 수익률을 S&amp;P 500과 비교

The Boeing Company (BA)

Earnings

Pre-Market Outlook

Trading Ideas

CLEU

IPHA

KARO

오늘 월요일 아침 미국 주식 선물이 약간 하락하고 있는 가운데, 오늘 투자자들의 관심을 끌 수 있는 주식은 다음과 같습니다: 1. 월스트리트는 카루(NASDAQ:KARO)가 분기 실적을 주당 39센트의 이익과 6,323만 달러의 매출로 발표할 것으로 예상하고 있다. Benzinga Pro의 데이터에 따르면, 카루(Karooooo)의 주식은 시간외 거래에서 14.4% 상승하여 50.00달러에 거래되었다.

월요일 주목해야 할 주식: 보잉, 누릭스 테라퓨틱스, 보잉, 인네이트 파마 및 차이나 리버럴

Nurix Therapeutics Inc

Trump Media and Technology Group Corp. (Nasdaq, NYSE Texas: <a href="https://www.benzinga.com/stock/djt#Nasdaq,%20NYSE%20Texas">DJT</a>) ("Trump Media" or the "Company"), operator of the social media platform Truth Social, the streaming platform Truth+, and the FinTech brand Truth.Fi, announced today that it has filed a registration statement on form S-3 ("Registration Statement") with the U.S. Securities and Exchange Commission ("SEC") related to debt and equity subscription agreements recently entered into with approximately fifty investors that yielded approximately $2.3 billion in total proceeds—one of the largest Bitcoin treasury deals for a public company. The proceeds will be used for the Company's creation of a Bitcoin treasury and for general corporate purposes.
In accordance with registration obligations in the previously-disclosed agreements, the Registration Statement seeks to register for resale by the investors approximately 56 million shares of equity and 29 million shares underlying convertible notes.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Trump Media Files SEC Registration Statement To Enable Resale Of Shares From $2.3B Bitcoin-Focused Financing Deal With 50 Investors

Combination will fast-track Genpact's expansion of advanced technology solutions, amplifying data and AI capabilities, domain expertise, and strategic partnerships&nbsp;&nbsp;
NEW YORK, June 5, 2025 /PRNewswire/ --&nbsp;Genpact (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/G#NYSE">G</a>), a global advanced technology services and solutions company, today announced it has acquired XponentL Data, a data products and artificial intelligence (AI) solutions provider. XponentL brings differentiated domain-led data strategy, design, and engineering capabilities; deep industry experience; and strategic partnerships. This acquisition builds on Genpact's pivot to data, AI, and other advanced technologies, further enhancing Genpact's ability to help clients across the lifecycle of AI transformation, from strategy through implementation.

Genpact Acquires XponentL Data; Financial Details Of The Transaction Were Not Disclosed.

Management

NAVI

Navient Elects Edward Bramson Chair Of The Board Of Directors

IAC Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IAC#NASDAQ">IAC</a>) ("IAC") announced today that its wholly owned subsidiary, Dotdash Meredith Inc. ("DDM"), has agreed to sell $400 million aggregate principal amount of 7.625% senior secured notes due 2032 (the "Notes") in a private offering (the "Offering").&nbsp; The Notes will bear interest at an interest rate of 7.625% per annum and will be issued at 100.00% of their face value.&nbsp; DDM's obligations under the Notes will be guaranteed on a senior secured basis by certain of DDM's subsidiaries.
DDM intends to use the proceeds of the offering, together with the borrowings under DDM's new $700.0 million term loan B facility and cash on hand, to repay all of the indebtedness outstanding under DDM's existing $1.18 billion term loan B-1 facility and to pay related fees and expenses.&nbsp; The closings of each of the Offering and new term loan B facility are expected to occur on or about June 16, 2025, each subject to the satisfaction of customary closing conditions.

Offerings

IAC's Dotdash Meredith, Has Agreed To Sell $400M Aggregate Principal Amount Of 7.625% Senior Secured Notes Due 2032

Air T, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRT#NASDAQ">AIRT</a>) announced on June 2nd the successful renegotiation of a key financing agreement involving its wholly owned subsidiary, AAM 24-1, LLC.
The updated agreement, reached with the Company's existing institutional investors, grows the transaction from $30,000,000 to $100,000,000, extends repayment timelines and increases financial flexibility. These changes support Air T's long-term capital foundation while maintaining alignment with its strategic objectives and commitment to growth.

Financing

AIRT

Air T Expands Key Financing Deal From $30M To $100M, Boosting Flexibility And Supporting Long-Term Growth Strategy

<h3>Gainers</h3>
<ul>
<li>Jiade (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JDZG#NASDAQ">JDZG</a>) shares moved upwards by 10.5% to $0.38 during Thursday's after-market session. The company's market cap stands at $9.2 million. </li>
<li>Rent the Runway (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RENT#NASDAQ">RENT</a>) stock increased by 10.15% to $7.7. The market value of their outstanding shares is at $30.9 million. As per the news, the Q1 earnings report came out today. </li>
<li>Yunji (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YJ#NASDAQ">YJ</a>) stock moved upwards by 7.85% to $2.06. The market value of their outstanding shares is at $40.5 million. </li>
<li>NWTN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWTN#NASDAQ">NWTN</a>) stock rose 6.17% to $1.72. The company's market cap stands at $492.2 million. </li>
<li>E-Home Household Service (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EJH#NASDAQ">EJH</a>) shares increased by 5.94% to $2.85. </li>
<li>Jianzhi Education Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JZ#NASDAQ">JZ</a>) shares rose 5.55% to $0.38. The company's market cap stands at $10.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Lululemon Athletica (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) stock decreased by 22.9% to $255.09 during Thursday's after-market session. The company's market cap stands at $31.9 billion. As per the news, the Q1 earnings report came out today. </li>
<li>Golden Heaven Group Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDHG#NASDAQ">GDHG</a>) shares declined by 13.73% to $1.32. The market value of their outstanding shares is at $21.6 million. </li>
<li>Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) shares decreased by 11.88% to $3.19. The market value of their outstanding shares is at $889.9 million. As per the news, the Q1 earnings report came out today. </li>
<li>Top Win International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SORA#NASDAQ">SORA</a>) stock decreased by 9.42% to $6.35. The market value of their outstanding shares is at $157.8 million. </li>
<li>Zumiez (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZUMZ#NASDAQ">ZUMZ</a>) shares decreased by 6.3% to $12.05. The company's market cap stands at $230.8 million. As per the news, the Q1 earnings report came out today. </li>
<li>Genius Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GNS#AMEX">GNS</a>) shares fell 5.53% to $0.34. The market value of their outstanding shares is at $24.3 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

GDHG

JDZG

LULU

NWTN

RENT

SORA

WOOF

ZUMZ

12 Consumer Discretionary Stocks Moving In Thursday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Bluejay Diagnostics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BJDX#NASDAQ">BJDX</a>) stock rose 41.5% to $2.15 during Thursday's after-market session. The market value of their outstanding shares is at $3.2 million. </li>
<li>GlycoMimetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLYC#NASDAQ">GLYC</a>) shares moved upwards by 30.86% to $0.26. The company's market cap stands at $16.7 million. </li>
<li>Eyenovia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EYEN#NASDAQ">EYEN</a>) shares increased by 28.97% to $4.05. The company's market cap stands at $11.6 million. </li>
<li>Pediatrix Medical Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MD#NYSE">MD</a>) shares moved upwards by 8.47% to $15.1. The company's market cap stands at $1.2 billion. </li>
<li>Rani Therapeutics Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RANI#NASDAQ">RANI</a>) shares increased by 7.27% to $0.57. The company's market cap stands at $19.0 million. </li>
<li>RAPT Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAPT#NASDAQ">RAPT</a>) stock rose 6.86% to $1.09. The company's market cap stands at $144.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Liminatus Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIMN#NASDAQ">LIMN</a>) shares declined by 18.7% to $20.0 during Thursday's after-market session. The company's market cap stands at $534.2 million. </li>
<li>Senti Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNTI#NASDAQ">SNTI</a>) shares decreased by 10.12% to $3.2. The market value of their outstanding shares is at $83.4 million. </li>
<li>Pheton Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTHL#NASDAQ">PTHL</a>) shares decreased by 9.44% to $8.06. The market value of their outstanding shares is at $116.8 million. </li>
<li>Universe Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPC#NASDAQ">UPC</a>) stock fell 8.15% to $3.86. The company's market cap stands at $58.7 million. </li>
<li>NewGenIvf Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIVF#NASDAQ">NIVF</a>) shares decreased by 7.83% to $2.12. The market value of their outstanding shares is at $1.5 million. </li>
<li>Scinai Immunotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCNI#NASDAQ">SCNI</a>) shares declined by 7.7% to $3.0. The company's market cap stands at $2.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BJDX

EYEN

GLYC

LIMN

NIVF

PTHL

RANI

RAPT

SCNI

SNTI

12 Health Care Stocks Moving In Thursday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Momentus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNTS#NASDAQ">MNTS</a>) shares moved upwards by 14.1% to $1.86 during Thursday's after-market session. The company's market cap stands at $10.2 million. </li>
<li>Virgin Galactic Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPCE#NYSE">SPCE</a>) shares increased by 11.5% to $3.49. The company's market cap stands at $145.0 million. </li>
<li>EuroDry (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EDRY#NASDAQ">EDRY</a>) shares moved upwards by 8.33% to $8.84. The market value of their outstanding shares is at $24.9 million. The company's, Q1 earnings came out today. </li>
<li>Quanex Building Prods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NX#NYSE">NX</a>) stock moved upwards by 7.19% to $18.32. The company's market cap stands at $865.2 million. The company's, Q2 earnings came out today. </li>
<li>Founder Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FGL#NASDAQ">FGL</a>) stock increased by 7.12% to $1.03. The company's market cap stands at $19.9 million. </li>
<li>Sidus Space (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIDU#NASDAQ">SIDU</a>) stock rose 6.44% to $1.57. The market value of their outstanding shares is at $28.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Concrete Pumping Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBCP#NASDAQ">BBCP</a>) stock decreased by 12.3% to $6.2 during Thursday's after-market session. The company's market cap stands at $328.9 million. The company's, Q2 earnings came out today. </li>
<li>iPower (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPW#NASDAQ">IPW</a>) shares declined by 11.96% to $0.5. The company's market cap stands at $15.6 million. </li>
<li>Linkers Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNKS#NASDAQ">LNKS</a>) stock fell 6.89% to $0.59. The company's market cap stands at $7.9 million. </li>
<li>Lucas GC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGCL#NASDAQ">LGCL</a>) stock decreased by 6.72% to $0.58. The company's market cap stands at $46.4 million. </li>
<li>ATIF Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZBAI#NASDAQ">ZBAI</a>) shares fell 6.71% to $0.63. The market value of their outstanding shares is at $10.9 million. </li>
<li>LanzaTech Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNZA#NASDAQ">LNZA</a>) stock decreased by 6.09% to $0.23. The company's market cap stands at $52.9 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BBCP

EDRY

LGCL

LNKS

LNZA

MNTS

SIDU

SPCE

ZBAI

12 Industrials Stocks Moving In Thursday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Ascent Solar Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTI#NASDAQ">ASTI</a>) stock moved upwards by 9.9% to $1.77 during Thursday's after-market session. The company's market cap stands at $3.2 million. </li>
<li>Abits Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABTS#NASDAQ">ABTS</a>) shares increased by 4.97% to $4.22. The company's market cap stands at $10.0 million. </li>
<li>Nano Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NA#NASDAQ">NA</a>) shares moved upwards by 4.95% to $7.2. The company's market cap stands at $120.1 million. </li>
<li>Expensify (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXFY#NASDAQ">EXFY</a>) shares rose 4.82% to $2.39. The market value of their outstanding shares is at $220.8 million. </li>
<li>SmartRent (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMRT#NYSE">SMRT</a>) shares moved upwards by 4.62% to $0.97. The market value of their outstanding shares is at $182.5 million. </li>
<li>Saverone 2014 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SVRE#NASDAQ">SVRE</a>) stock moved upwards by 4.42% to $1.18. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Docusign (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOCU#NASDAQ">DOCU</a>) stock declined by 16.0% to $78.05 during Thursday's after-market session. The market value of their outstanding shares is at $15.8 billion. As per the news, the Q1 earnings report came out today. </li>
<li>MicroCloud Hologram (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOLO#NASDAQ">HOLO</a>) stock decreased by 14.63% to $4.44. The market value of their outstanding shares is at $22.7 million. </li>
<li>ServiceTitan (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTAN#NASDAQ">TTAN</a>) shares declined by 12.76% to $99.94. The market value of their outstanding shares is at $8.9 billion. As per the press release, Q1 earnings came out today. </li>
<li>Samsara (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IOT#NYSE">IOT</a>) shares declined by 11.54% to $41.8. The company's market cap stands at $23.7 billion. The company's, Q1 earnings came out today. </li>
<li>Braze (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRZE#NASDAQ">BRZE</a>) stock fell 9.06% to $32.84. The company's market cap stands at $3.4 billion. As per the news, the Q1 earnings report came out today. </li>
<li>BitMine Immersion Technologies, Inc. Common Stock (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BMNR#AMEX">BMNR</a>) stock fell 8.91% to $7.06. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ABTS

ASTI

BMNR

BRZE

DOCU

EXFY

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

SMRT

SVRE

TTAN

12 Information Technology Stocks Moving In Thursday's After-Market Session

VEON Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VEON#NASDAQ">VEON</a>) ("VEON"), a global digital operator, announces the public filing of a registration statement on Form F-4 (the "Registration Statement") with the U.S. Securities and Exchange Commission ("SEC") in connection with the listing of Kyivstar Group Ltd. ("Kyivstar Group"), the parent company of Ukraine's leading digital operator JSC Kyivstar, on the Nasdaq Stock Market LLC ("Nasdaq").
This filing represents a milestone in VEON's plans to list Kyivstar Group on Nasdaq following the anticipated completion of a business combination with Cohen Circle Acquisition Corp. I (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCIR#NASDAQ">CCIR</a>) ("Cohen Circle") that was announced on March 18, 2025. At the closing of the transaction, the business combination will result in the listing of Kyivstar Group's common shares and warrants on Nasdaq under the ticker symbols "KYIV" and "KYIVW," respectfully, as the only pure-play Ukrainian investment opportunity on U.S. stock markets.

CCIR

VEON

VEON Files Registration Statement With SEC To List Kyivstar Group On Nasdaq Following Planned Merger With Cohen Circle Under Tickers "KYIV"

Saputo (TSX:<a class="ticker" href="https://www.benzinga.com/stock/SAP#TSX">SAP</a>) reported quarterly earnings of $0.30 per share which missed the analyst consensus estimate of $0.34 by 11.76 percent. This is a 18.92 percent decrease over earnings of $0.37 per share from the same period last year. The company reported quarterly sales of $4.75 billion which beat the analyst consensus estimate of $4.74 billion by 0.27 percent. This is a 4.58 percent increase over sales of $4.54 billion the same period last year.

Earnings Beats

Earnings Misses

TSX:SAP

Saputo Q4 Adj. EPS $0.30 Misses $0.34 Estimate, Sales $4.75B Beat $4.74B Estimate

Vail Resorts Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTN#NYSE">MTN</a>) reported financial results for the third quarter on Thursday after the bell. Here&#8217;s a look at the key details <a href="https://www.benzinga.com/pressreleases/25/06/n45802286/vail-resorts-reports-fiscal-2025-third-quarter-results-provides-updated-fiscal-2025-guidance-and-p">from the print</a>.
Q3 Earnings: Vail Resorts reported third-quarter revenue of $1.29 billion, narrowly missing estimates of $1.3 billion, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>. The company reported third-quarter earnings of $10.54 per share, beating estimates of $10.12 per share. 
Total revenue was up 1% year-over-year. Pass product sales&nbsp;for the upcoming 2025/2026 North American ski season decreased approximately&nbsp;1%&nbsp;in units, but increased approximately&nbsp;2%&nbsp;in sales dollars.
Vail Resorts&#8217; board declared a quarterly cash dividend of $2.22 per share, payable on July 9 to shareholders of record as of June 24. 
&#8220;Results in the quarter reflect the stability provided by our season pass program as Resort net revenue, excluding Crans-Montana, remained consistent with the prior year even as visitation declined 7%,&#8221; said Rob Katz, CEO of Vail Resorts.
&#8220;Our performance throughout the 2024/2025 North American ski season reflects the strength of our advance commitment strategy, strong destination guest spending, and the impact of our resource efficiency transformation plan.&#8221;
Vail announced at the end of May that Katz was taking over as CEO for Kirsten Lynch, who decided to step down from the role. 
Vail said it expects to achieve $100 million in annualized cost efficiencies by the end of fiscal 2026 due to the company&#8217;s two-year resource efficiency transformation plan, announced in September 2024.
Outlook: The company expects fiscal 2025 net income attributable to Vail Resorts to be between&nbsp;$264 million&nbsp;and&nbsp;$298 million, and Resort Reported EBITDA for fiscal 2025 to be between&nbsp;$831 million&nbsp;and&nbsp;$851 million.&nbsp;
&#8220;The guidance reflects the lower than expected lift ticket visitation in the spring period that was partially mitigated by the Company&#8217;s focus on its resource efficiency transformation plan and strong cost discipline,&#8221; the company said.
Vail Resorts executives will further discuss the quarter on a conference call set for 5 p.m. ET.
MTN Price Action:&nbsp;<a href="http://benzinga.com/quote/MTN" target="_blank" rel="noreferrer noopener">Vail Resorts shares</a>&nbsp;were down 1.04% in after-hours, trading at $153.33 at the time of publication Thursday, according to&nbsp;<a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/earnings/25/06/45803051/docusign-stock-plummets-after-q1-earnings-report-details">DocuSign Stock Plummets After Q1 Earnings Report: Details</a></li>
<li><a href="https://www.benzinga.com/markets/earnings/25/06/45803595/broadcom-q2-earnings-revenue-eps-beat-estimates-driven-by-robust-demand-for-ai-networking-company-sees-acceleration-in-ai-revenue-ahead">Broadcom Q2 Earnings: Revenue, EPS Beat Estimates Driven By &#8216;Robust Demand&#8217; For AI Networking, Company Sees Acceleration In AI Revenue Ahead</a></li>
</ul>
Photo: Tint Media/Shutterstock.

Guidance

Travel

Sports

After-Hours Center

Vail Resorts Stock Slides On Q3 Earnings, Company Targets $100 Million In Annualized Cost Efficiencies

Enghouse Systems (TSX:<a class="ticker" href="https://www.benzinga.com/stock/ENGH#TSX">ENGH</a>) reported quarterly earnings of $0.24 per share which missed the analyst consensus estimate of $0.37 by 35.14 percent. This is a 33.33 percent decrease over earnings of $0.36 per share from the same period last year. The company reported quarterly sales of $124.82 million which missed the analyst consensus estimate of $129.48 million by 3.60 percent. This is a 0.79 percent decrease over sales of $125.81 million the same period last year.

TSX:ENGH

Enghouse Systems Q2 EPS $0.24 Misses $0.37 Estimate, Sales $124.82M Miss $129.48M Estimate

In the current market session, Frontline Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FRO#NYSE">FRO</a>) share price is at $18.13, after a 0.17% drop. Over the past month, the stock went up by 5.96%, but over the past year, it actually decreased by 30.93%. With good short-term performance like this, and questionable long-term performance, long-term shareholders might want to start looking into the company's price-to-earnings ratio.

<img src="https://www.benzinga.com/files/images/story/2025/1749157220_0.png" alt="Past Year Chart" />

<h3>Comparing Frontline P/E Against Its Peers</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Compared to the aggregate P/E ratio of the 76.1 in the Oil, Gas &amp; Consumable Fuels industry, Frontline Inc. has a lower P/E ratio of 11.57. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1749157220_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

A Look Into Frontline Inc's Price Over Earnings

Northern Oil &amp; Gas (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOG#NYSE">NOG</a>) has outperformed the market over the past 5 years by 4.64% on an annualized basis producing an average annual return of 17.71%. Currently, Northern Oil &amp; Gas has a market capitalization of $2.74 billion. 
Buying $100 In NOG: If an investor had bought $100 of NOG stock 5 years ago, it would be worth $220.63 today based on a price of $27.80 for NOG at the time of writing.
<h3>Northern Oil &amp; Gas's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749157219_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $100 Invested In Northern Oil & Gas 5 Years Ago Would Be Worth Today

WIIM

TBH stock has given up its prior loss. Brag House Holdings shares were trading lower after the company announced it is working to file its delayed Q1 10-Q report.

Microsoft Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) shares surged to a new all-time high of $469.65 on Thursday before closing up 0.82% at $467.68, despite no company-specific news. The rally comes as broader market trends continue to favor mega-cap tech stocks, especially those leading in artificial intelligence and cloud computing.
What To Know: A recent software spending survey by BofA Securities analyst Brad Sills <a href="https://www.benzinga.com/markets/large-cap/25/06/45755544/rising-ai-analytics-budgets-could-lift-microsoft-snowflake-datadog">signaled</a> modest declines in software growth expectations for 2025 and 2026, citing macroeconomic uncertainties. 
Still, spending is projected to grow nearly 10% annually, with data analytics, cloud communications and security remaining top priorities. Microsoft, Snowflake and Datadog are seen as key beneficiaries in analytics, security and cloud infrastructure.
Read Also: <a href="https://www.benzinga.com/markets/tech/25/06/45800099/palantir-ceo-alex-karp-refutes-ridiculous-surveillance-reports-says-company-is-winning">Palantir CEO Alex Karp Refutes &#8216;Ridiculous&#8217; Surveillance Reports, Says Company Is &#8216;Winning&#8217;</a>
Meanwhile, strong corporate earnings are <a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/45758803/sp-500-q1-earnings-stun-again-the-street-with-broad-based-beats-double-digit-growth">fueling</a> bullish sentiment. Nearly 80% of S&amp;P 500 firms topped first-quarter expectations, delivering a 13.3% profit increase. Microsoft was among six of the Magnificent Seven to beat estimates, contributing to a collective $1.75 trillion market cap gain in May, the group's best month in years.
Analysts warn valuations are <a href="https://www.benzinga.com/etfs/specialty-etfs/25/06/45775924/david-mazza-on-mags-magnificent-may-the-breadth-of-the-rally-stood-out">stretched</a>, with Microsoft trading at a forward P/E near 27. But investors continue to reward firms with robust AI-driven growth and durable business models, positioning Microsoft as a leader in the next wave of tech innovation.
Read Also: <a href="https://www.benzinga.com/markets/market-summary/25/06/45798808/trump-announces-china-trade-talks-tesla-stock-slumps-whats-driving-markets-thursday">Trump Announces China Trade Talks, Tesla Stock Slumps: What&#8217;s Driving Markets Thursday?</a>
<h1 class="wp-block-heading">How To Buy MSFT Stock</h1>
Besides going to a brokerage platform to purchase a share — or fractional share — of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.
For example, Microsoft is in the Information Technology sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, MSFT has a 52-week high of $469.65 and a 52-week low of $344.79.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/reiteration/25/06/45801194/why-analyst-sees-attractive-valuation-for-calvin-klein-parent-pvh-despite-noisy-q1#google_vignette" target="_blank" rel="noreferrer noopener">Why Analyst Sees Attractive Valuation For Calvin Klein Parent PVH Despite ‘Noisy' Q1</a></li>
</ul>
Image: Shutterstock

MSFT

Microsoft Hits Record High Amid Strong Tech Sector Momentum: What's Going On?

&nbsp;<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4443269-1&amp;h=2738165566&amp;u=https%3A%2F%2Fnauticusrobotics.com%2F&amp;a=Nauticus+Robotics%2C+Inc.">Nauticus Robotics, Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KITT#NASDAQ">KITT</a>), a leading innovator in autonomous subsea robotics and software solutions, today announced a strategic collaboration with <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4443269-1&amp;h=1936341460&amp;u=https%3A%2F%2Fwww.openoceanrobotics.com%2F&amp;a=Open+Ocean+Robotics">Open Ocean Robotics</a>, a pioneer in uncrewed surface vehicles (USVs) that enable safe, cost-effective, and environmentally sustainable ocean monitoring. Together, the companies aim to deliver cutting-edge technologies that will redefine how the energy sector approaches subsea asset management.
The collaboration brings together Nauticus' expertise in subsea robotics, including autonomous systems like the Aquanaut&#xAE;, and Open Ocean Robotics' solar-powered USV, the DataXplorer&#x2122;. The collaboration is designed to significantly reduce the high operational costs typically associated with subsea inspections, maintenance, and monitoring—while simultaneously delivering a compelling environmental advantage. The joint solution pairs autonomous subsea vehicles with surface-based USVs to offer persistent, real-time monitoring and data collection while minimizing the need for costly crewed vessels. This collaboration will enable energy operators to conduct autonomous inspections and monitoring of critical infrastructure—such as pipelines, risers, and subsea manifolds—more frequently, efficiently, and with significantly lower environmental impact.

KITT

Nauticus Robotics Announces Strategic Collaboration With Open Ocean Robotics To Combine Autonomous Subsea Vehicles And Solar-Powered USVs

Ciena (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIEN#NYSE">CIEN</a>) FY2025 sales expected to up by 14% YoY.

CIEN

Ciena FY2025 Sales expected to up by 14% YoY.

General

NOVA

Sunnova Energy International Co's Unit Files For Chapter 11 Bankruptcy; To Reduce Workforce By 55%, Impacting 718 Employees;  Robyn Liska Remains Interim CFO; TEPD Bankruptcy Filing Not Expected To Affect Servicing Operations

Press Releases

Nurix Therapeutics Reports First Quarter 2025 Financial Results and Provides a Corporate Update

Health Care

Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Nurix Announces FDA Clearance of IND Application for GS-6791/NX-0479 - a Novel IRAK4 Degrader for Inflammatory Conditions

Nurix Therapeutics Presents Positive Preclinical Data at the AACR 2025 Annual Meeting from Multiple Orally Available, Brain Penetrant Degraders Against Three High Value Oncology Targets

Nurix Therapeutics Presents Data at the AACR 2025 Annual Meeting Highlighting the Transformative Potential of Its Proprietary DEL-AI Platform Leveraging Machine Learning to Speed the Discovery of Novel Drugs

Nurix Therapeutics Announces Presentations of Clinical Data at the 30th European Hematology Association Congress and the 18th International Conference on Malignant Lymphoma

Nurix Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference

Comments

Nurix Therapeutics

매도 수량

Nurix Therapeutics (NASDAQ:NRIX) 주식, 공매도 수량 보고

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌